Baldwin Insurance Group, Inc.: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Nov 4, 2025 and accepted by EDGAR at Nov 4, 2025, 16:42 ET.
Management's discussion and analysis
As filed, 78,361 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 25, 2025. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024.
THE COMPANY
The Baldwin Insurance Group, Inc. is a holding company and sole managing member of The Baldwin Insurance Group Holdings, LLC (formerly Baldwin Risk Partners, LLC) (“Baldwin Holdings”) and its sole material asset is its ownership interest in Baldwin Holdings, through which all of our business has been and is conducted. In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the words “Baldwin,” the “Company,” “we,” “us” and “our” refer to The Baldwin Insurance Group, Inc., together with its consolidated subsidiaries, including Baldwin Holdings and its consolidated subsidiaries and affiliates.
Baldwin is an independent insurance distribution firm providing indispensable expertise and insights that strive to give our clients the confidence to pursue their purpose, passion and dreams. As a team of dedicated entrepreneurs and insurance professionals, we have come together to help protect the possible for our clients. We do this by delivering bespoke client solutions, services, and innovation through our comprehensive and tailored approach to risk management, insurance, and employee benefits. We support our clients, colleagues, insurance company partners and communities through the deployment of vanguard resources and capital to drive our organic and inorganic growth. When we consistently execute for these key stakeholders, we believe that the outcome is an increase in value for our fifth stakeholder, our stockholders. We are innovating the industry by taking a holistic and tailored approach to risk management, insurance and employee benefits. Our growth plan includes continuing to recruit, train and develop industry leading talent, continuing to add geographic representation, insurance product expertise and end-client industry expertise via our partnership strategy, and continuing to expand our product suite and sources of capacity through our MGA platform (“MSI”), which delivers proprietary, technology-enabled insurance solutions to our internal risk advisors as well as to a growing channel of external distribution partners. We are a destination employer supported by an award-winning culture, powered by exceptional people and fueled by industry-leading growth and innovation.
We represent over three million clients across the United States and internationally. Our 4,000 plus colleagues include approximately 700 risk advisors, who are fiercely independent, relentlessly competitive and “insurance geeks.” We have approximately 110 offices in 23 states, all of which are equipped to provide diversified products and services to empower our clients at every stage through our three operating groups.
- **Insurance Advisory Solutions (“**IAS”) provides expertly-designed commercial risk management, employee benefits and private risk management solutions for businesses and high-net-worth individuals, as well as their families. Risk management solutions typically involve the sale of a wide variety of both commercial and personal lines insurance products that mitigate risks for firms and individuals. Employee benefits solutions can include health plans, dental plans, and retirement accounts for firms and their employees. We are privileged to have partnered with some of the highest quality independent insurance brokers across the country with vast and varied strategic capabilities and expertise. We have been intentional in recognizing and elevating this talent across the organization to build world class industry-focused practice groups and product Centers of Excellence that can be leveraged by the entire firm.
- **Underwriting, Capacity & Technology Solutions (“**UCTS”) consists of three distinct divisions—MSI, our Capacity Solutions group (which includes our reinsurance brokerage business, Juniper Re, our reinsurance MGA business, MultiStrat, and our captive management business), and the Captive business. Through MSI, we manufacture proprietary, technology-enabled insurance products that are then distributed (in many instances via technology and/or API integrations) internally via our risk advisors across our other operating groups and externally via select distribution partners, with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, an example of which is the national embedded renters insurance product sold at point of lease via integrations with property management software providers. As a prominent growth driver for the Company, we have invested heavily in the expansion of our MGA product suite, which is now comprised of more than 20 products across commercial, personal and professional lines. In 2024, we made significant investment in the development of new middle-market oriented commercial lines products, two of which have gone live in the first half of 2025. UCTS’ Wholesale Business was sold in the first quarter of 2024, and its operations are included in our results through the end of February 2024.
In January 2025, we received final approval and a Certificate of Authority from the Texas Department of Insurance to form a Texas-domiciled reciprocal insurance exchange (the “Reciprocal”), for which we serve as the Attorney-in-Fact (the “AIF”). The third-party led capitalization of the Reciprocal closed and funded in full on May 6, 2025, and we began writing business into the Reciprocal late in the second quarter of 2025. Based on the structure of the Reciprocal, we do not consolidate the Reciprocal’s financial results, and the AIF entity is treated as an equity method investment in UCTS.
UCTS includes TBG Assurance Company, LLC, a wholly-owned protected cell captive insurance company (“PCC”) domiciled in Tennessee, which was established to allow Baldwin to further participate in the underwriting results of a small portion of its MGA programs. The PCC allows for the creation of multiple independent cells (series) within a single legal entity, TBG Assurance Company, LLC (the “Core”). The initial series, MSI Multifamily Series Protected Cell (the “MSI Cell” and, collectively with the Core, the “Captive”) became effective January 1, 2025.
- **Mainstreet Insurance Solutions (“**MIS”) offers personal insurance, commercial insurance and life and health solutions to individuals and businesses in their communities, with a focus on accessing clients via sheltered distribution channels, which include, but are not limited to, new home builders, realtors, mortgage originators/lenders, master planned communities, and various other community centers of influence. We have invested deeply in talent, technology and capabilities across MIS, including in Westwood's homeowners solutions that are embedded in many of the top home builders in the United States, the national expansion of our distribution footprint through our National Mortgage and Real Estate Center, and enhanced digital capabilities focused on improving the advisor and client experience. Mainstreet Insurance Solutions also offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents.
In 2011, we adopted the “Azimuth” as our corporate and cultural constitution. Named after a historical navigation tool used to find “true north,” the Azimuth asserts our core values, business basics and stakeholder promises. The ideals encompassed by the Azimuth support our mission to deliver indispensable, tailored insurance and risk management insights and solutions to our clients. We strive to be regarded as the preeminent insurance advisory firm—fueled by relationships, powered by people and exemplified by client adoption and loyalty. This type of environment is upheld by the distinct vernacular we use to describe our services and culture. We are a firm, instead of an agency; we have colleagues, instead of employees; and we have risk advisors, instead of producers/agents. We serve clients instead of customers and we refer to our strategic acquisitions as partnerships. We refer to insurance brokerages that we have acquired, or in the case of asset acquisitions, the producers, as partners.
Seasonality
The insurance brokerage market is seasonal and our results of operations are somewhat affected by seasonal trends. Our adjusted EBITDA and adjusted EBITDA margin are typically highest in the first quarter and lowest in the fourth quarter. This variation is primarily due to fluctuations in our revenues, while overhead remains consistent throughout the year. Our revenues are generally highest in the first quarter due to a higher degree of first quarter policy commencements and renewals in certain Insurance Advisory Solutions and Mainstreet Insurance Solutions lines of business such as employee benefits, commercial and Medicare. In addition, a higher proportion of our first quarter revenue is derived from our highest margin businesses.
Partnerships can significantly impact adjusted EBITDA and adjusted EBITDA margin in a given year and may increase the amount of seasonality within the business, especially results attributable to partnerships that have not been fully integrated into our business or owned by us for a full year.
RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements for the three and nine months ended September 30, 2025 and 2024 and the related notes and other financial information included elsewhere in this report.
In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024.
The following is a discussion of our consolidated results of operations for the three and nine months ended September 30, 2025 and 2024.
(in thousands)
| Revenues: | For the Three Months Ended September 30, 2025 | 2024 | Variance Amount% | For the Nine Months Ended September 30, 2025 | 2024 | Variance Amount% | ||
|---|---|---|---|---|---|---|---|---|
| Core commissions and fees | $330,820 | $305,530 | $25,290 | 8% | $1,063,925 | $974,314 | $89,611 | 9% |
| Profit-sharing and other income | 31,497 | 29,680 | 1,817 | 6% | 85,172 | 76,095 | 9,077 | 12% |
| Commissions and fees | 362,317 | 335,210 | 27,107 | 8% | 1,149,097 | 1,050,409 | 98,688 | 9% |
| Investment income | 3,072 | 3,728 | (656) | (18)% | 8,508 | 8,736 | (228) | (3)% |
| Total revenues | 365,389 | 338,938 | 26,451 | 8% | 1,157,605 | 1,059,145 | 98,460 | 9% |
| Operating expenses: | ||||||||
| Colleague compensation and benefits | 193,031 | 172,645 | 20,386 | 12% | 586,522 | 549,359 | 37,163 | 7% |
| Outside commissions | 79,111 | 74,544 | 4,567 | 6% | 218,520 | 204,237 | 14,283 | 7% |
| Other operating expenses | 56,008 | 48,839 | 7,169 | 15% | 170,146 | 141,198 | 28,948 | 21% |
| Amortization expense | 30,394 | 26,899 | 3,495 | 13% | 82,286 | 76,334 | 5,952 | 8% |
| Change in fair value of contingent consideration | 1,980 | (952) | 2,932 | n/m | 8,084 | 17,276 | (9,192) | (53)% |
| Depreciation expense | 1,649 | 1,557 | 92 | 6% | 4,874 | 4,619 | 255 | 6% |
| Total operating expenses | 362,173 | 323,532 | 38,641 | 12% | 1,070,432 | 993,023 | 77,409 | 8% |
| Operating income | 3,216 | 15,406 | (12,190) | (79)% | 87,173 | 66,122 | 21,051 | 32% |
| Other income (expense): | ||||||||
| Interest expense, net | (31,132) | (31,329) | 197 | (1)% | (92,428) | (94,203) | 1,775 | (2)% |
| Gain on divestitures | — | 1,809 | (1,809) | (100)% | 290 | 38,953 | (38,663) | (99)% |
| Loss on extinguishment and modification of debt | (3,290) | (389) | (2,901) | n/m | (5,684) | (15,068) | 9,384 | (62)% |
| Other income, net | 860 | 28 | 832 | n/m | 745 | 105 | 640 | n/m |
| Total other expense, net | (33,562) | (29,881) | (3,681) | 12% | (97,077) | (70,213) | (26,864) | 38% |
| Loss before income taxes and share of net earnings of equity method investment | $(30,346) | $(14,475) | $(15,871) | 110% | $(9,904) | $(4,091) | $(5,813) | 142% |
n/m not meaningful
Commissions and Fees
We earn commissions and fees by facilitating the arrangement between insurance company and reinsurance company partners and clients for the insurance and/or reinsurance company to provide insurance and/or reinsurance to the insured party. Our commissions are usually a percentage of the premium paid by the insured and generally depend on the type of insurance, the particular insurance or reinsurance company partner and the nature of the services provided. Under certain arrangements with clients, we earn pre-negotiated service fees for insurance placement services. Additionally, we earn policy fees for acting in the capacity of an MGA and fulfilling certain administrative functions on behalf of insurance or reinsurance company partners, including delivery of policy documents, processing payments and other administrative functions, and the Captive business earns revenue from assumed premium. We may also receive profit-sharing commissions, which represent forms of variable consideration paid by insurance company partners and reinsurance company partners associated with the placement of coverage. Profit-sharing commissions are generally based on underwriting results, but may also contain considerations for volume, growth or retention. Other revenue streams include other ancillary income, premium financing income, and marketing income based on negotiated cost reimbursement for fulfilling specific targeted Medicare marketing campaigns.
Commissions and fees increased $27.1 million, or 8%, for the quarter ended September 30, 2025 compared to the same period of 2024, driven by organic growth in core commissions and fees of $13.7 million related to continued outperformance from MSI, commissions and fees contributed by partnership activity of $12.2 million, and organic growth in profit-sharing and other revenue of $1.5 million.
Commissions and fees increased $98.7 million, or 9%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by organic growth in core commissions and fees of $82.6 million related to new and renewal business across client industry sectors and continued outperformance from MSI, commissions and fees contributed by partnership activity of $14.2 million, and organic growth in profit-sharing and other revenue of $8.8 million, which is largely the result of improvements in loss ratios and the number of policies sold in MIS. This growth was offset in part by a decrease in core commissions and fees of $5.5 million related to the divestiture of our Wholesale Business in the first quarter of 2024. Core commissions and fees growth, excluding revenue related to the Wholesale Business during 2024, was 10%.
Colleague Compensation and Benefits
Colleague compensation and benefits is our largest expense. It consists of (i) base compensation comprising salary, bonuses and benefits paid and payable to colleagues, and commissions paid to colleagues, and (ii) equity-based compensation associated with the grants of restricted and unrestricted stock awards to senior management, colleagues, risk advisors and directors. We expect to continue to experience a general rise in colleague compensation and benefits expense commensurate with expected revenue growth as our compensation arrangements with our colleagues and risk advisors contain significant bonus or commission components driven by the results of our operations. In addition, we operate in competitive markets for human capital and need to maintain competitive compensation levels as we expand geographically and create new products and services.
Colleague compensation and benefits expense increased $20.4 million, or 12%, for the quarter ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $3.1 million to the increase in colleague compensation and benefits during the third quarter of 2025. After excluding colleague compensation and benefits expense related to partnership activity, colleague compensation and benefits increased $17.3 million, primarily resulting from the overall growth of the business.
Colleague compensation and benefits expense increased $37.2 million, or 7%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $4.5 million to the increase in colleague compensation and benefits year-to-date in 2025, offset in part by a $1.4 million decrease related to our Wholesale Business, which was sold in the first quarter of 2024. After excluding colleague compensation and benefits expense related to our partnerships and divestitures, colleague compensation and benefits increased $34.0 million, primarily resulting from the overall growth of the business.
Outside Commissions
Outside commissions increased $4.6 million, or 6%, for the quarter ended September 30, 2025 compared to the same period of 2024. Outside commissions increased at a lower rate than core commissions and fees primarily due to continued scaling of our UCTS business, product mix shift and contributions from the Capacity Solutions group (which generally does not have significant outside commissions).
Outside commissions increased $14.3 million, or 7%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024. After excluding outside commissions of $3.0 million earned by the Wholesale Business during 2024 for which there was no comparable expense in 2025, outside commissions increased $17.3 million, or 9%, which was in line with core commissions and fees.
Other Operating Expense
Other operating expenses include travel, accounting, legal and other professional fees, placement fees, rent, office expenses and other costs associated with our operations. Our occupancy-related costs and professional services expenses, in particular, generally increase or decrease in relative proportion to the number of our colleagues and the overall size and scale of our business operations.
Other operating expenses increased $7.2 million for the quarter ended September 30, 2025 compared to the same period of 2024, driven by higher incurred losses and LAE of $5.1 million related to our newly-established Captive business and professional fees of $1.4 million due to increased legal spend.
Other operating expenses increased $28.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024 driven by higher incurred losses and LAE of $14.0 million related to our newly-established Captive business, professional fees of $6.9 million due to increased legal spend, which includes fees related to the setup of the Reciprocal, advertising and marketing of $3.7 million in connection with the continued rollout of our rebranding, technology and software-related costs of $2.5 million, and licenses and taxes of $1.8 million due to growth in the business.
Amortization Expense
Amortization expense increased $3.5 million and $6.0 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, driven by our partnership activity and an increase in capitalized software.
Change in Fair Value of Contingent Consideration
The change in fair value of contingent consideration was a $2.0 million loss for the quarter ended September 30, 2025 compared to a $1.0 million gain for the same period of 2024, and a $8.1 million loss for the year-to-date period ended September 30, 2025 compared to a $17.3 million loss for the same period of 2024. The fair value loss related to contingent consideration for the third quarter of 2025 was impacted by positive changes in revenue growth trends of certain partners. The fair value loss related to contingent consideration for the year-to-date period of 2025 was impacted by positive changes in revenue growth trends of certain partners and accretion of the contingent earnout obligations approaching their respective measurement dates, in addition to a loss recognized in reclassifying $1.8 million of earnouts from colleague compensation and benefits.
Interest Expense, Net
Interest expense, net, was relatively flat for the third quarter of 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset by higher average borrowings.
Interest expense, net, decreased $1.8 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset in part by higher average borrowings. We expect interest expense to remain relatively flat in the near term on a year-over-year basis due to higher borrowings under our Revolving Facility to fund the settlement of deferred payment obligations and certain partnership opportunities, offset by lower expected average interest rates.
Gain on Divestitures
Gain on divestitures decreased $38.7 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by a $35.1 million gain recorded during 2024 in connection with the sale of our Wholesale Business.
Loss on Extinguishment and Modification of Debt
Loss on extinguishment and modification of debt of $3.3 million for the quarter ended September 30, 2025 relates to the September 2025 Refinancing.
Loss on extinguishment and modification of debt of $5.7 million for the year-to-date period ended September 30, 2025 relates to the 2025 Refinancings. Loss on extinguishment and modification of debt of $15.1 million for the year-to-date period ended September 30, 2024 relates to a debt refinancing completed in May 2024.
NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA, adjusted EBITDA margin, organic revenue, organic revenue growth, adjusted net income and adjusted diluted earnings per share (“EPS”), are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for organic revenue and organic revenue growth), net income (loss) (for adjusted EBITDA and adjusted EBITDA margin), net income (loss) attributable to Baldwin (for adjusted net income) or diluted earnings (loss) per share (for adjusted diluted EPS), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to Baldwin, diluted earnings (loss) per share or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly, these measures may not be comparable to similarly titled measures used by other companies.
We define adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, severance, and certain non-recurring items, including those related to raising capital. We believe that adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.
Adjusted EBITDA margin is calculated as adjusted EBITDA divided by total revenue. Adjusted EBITDA margin is a key metric used by management and our board of directors to assess our financial performance. We believe that adjusted EBITDA margin is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that adjusted EBITDA margin is helpful in measuring profitability of operations on a consolidated level.
Adjusted EBITDA and adjusted EBITDA margin have important limitations as analytical tools. For example, adjusted EBITDA and adjusted EBITDA margin:
- do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;
- do not reflect changes in, or cash requirements for, our working capital needs;
- do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;
- do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;
- do not reflect share-based compensation expense and other non-cash charges; and
- exclude certain tax payments that may represent a reduction in cash available to us.
We calculate organic revenue based on commissions and fees for the relevant period by excluding (i) the first twelve months of commissions and fees generated from new partners and (ii) commissions and fees from divestitures. Organic revenue growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period because the relevant partners had not yet reached the twelve-month owned mark, but which have reached the twelve-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue. For example, commissions and fees from a partner acquired on June 1, 2024 are excluded from organic revenue for 2024. However, after June 1, 2025, results from June 1, 2024 to December 31, 2024 for such partners are compared to results from June 1, 2025 to December 31, 2025 for purposes of calculating organic revenue growth in 2025. Organic revenue growth is a key metric used by management and our board of directors to assess our financial performance. We believe that organic revenue and organic revenue growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.
We define adjusted net income as net income (loss) attributable to Baldwin adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance.
Adjusted diluted EPS measures our per share earnings excluding certain expenses as discussed above for adjusted net income and assuming all shares of Class B common stock were exchanged for Class A common stock on a one-for-one basis. Adjusted diluted EPS is calculated as adjusted net income divided by adjusted diluted weighted-average shares outstanding. We believe adjusted diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.
Adjusted EBITDA and Adjusted EBITDA Margin
The following table reconciles adjusted EBITDA and adjusted EBITDA margin to net loss, which we consider to be the most directly comparable GAAP financial measure:
(in thousands, except percentages)
| For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Revenues | $365,389 | $338,938 | $1,157,605 | $1,059,145 |
| Net loss | $(30,237) | $(14,475) | $(10,480) | $(6,242) |
| Adjustments to net loss: | ||||
| Interest expense, net | 31,971 | 31,329 | 93,267 | 94,203 |
| Amortization expense | 30,394 | 26,899 | 82,286 | 76,334 |
| Share-based compensation | 22,017 | 17,949 | 51,772 | 46,764 |
| Change in fair value of contingent consideration | 1,980 | (952) | 8,084 | 17,276 |
| Transaction-related partnership and integration expenses | 2,376 | 2,047 | 7,894 | 9,042 |
| Loss on extinguishment and modification of debt | 3,290 | 389 | 5,684 | 15,068 |
| Depreciation expense | 1,649 | 1,557 | 4,874 | 4,619 |
| Severance | 1,620 | 678 | 4,445 | 3,554 |
| Income and other taxes(1) | 470 | 82 | 3,289 | 3,300 |
| Transformation costs | 3,638 | — | 4,410 | — |
| Colleague earnout incentives | — | 4,327 | (1,779) | 10,706 |
| Impairment of right-of-use assets | 66 | — | 1,254 | — |
| Gain on divestitures | — | (1,809) | (290) | (38,953) |
| Loss on interest rate caps | — | 84 | 18 | 244 |
| Other(2) | 3,286 | 4,646 | 17,099 | 13,410 |
| Adjusted EBITDA | $72,520 | $72,751 | $271,827 | $249,325 |
| Net loss margin | (8)% | (4)% | (1)% | (1)% |
| Adjusted EBITDA margin | 20% | 21% | 23% | 24% |
(1) Income and other taxes include the Tax Receivable Agreement expense and other operating tax expense, such as state taxes, under GAAP.
(2) Other addbacks to adjusted EBITDA include certain income and expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
Organic Revenue and Organic Revenue Growth
The following table reconciles organic revenue and organic revenue growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:
(in thousands, except percentages)
| For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Commissions and fees | $362,317 | $335,210 | $1,149,097 | $1,050,409 |
| Partnership commissions and fees(1) | (12,222) | — | (14,202) | — |
| Organic revenue | $350,095 | $335,210 | $1,134,895 | $1,050,409 |
| Organic revenue growth(2) | $15,177 | $40,672 | $91,369 | $144,844 |
| Organic revenue growth %(2) | 5% | 14% | 9% | 16% |
(1) Includes the first twelve months of such commissions and fees generated from newly acquired partners.
(2) Organic revenue for the three and nine months ended September 30, 2024 used to calculate organic revenue growth for the three and nine months ended September 30, 2025 was $334.9 million and $1.044 billion, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2025 and 2024.
Adjusted Net Income and Adjusted Diluted EPS
The following table reconciles adjusted net income to net loss attributable to Baldwin and reconciles adjusted diluted EPS to diluted loss per share, which we consider to be the most directly comparable GAAP financial measures:
(in thousands, except per share data)
| For the Three Months Ended September 30, 2025 | 2024 | For the Nine Months Ended September 30, 2025 | 2024 | |
|---|---|---|---|---|
| Net loss attributable to Baldwin | $(18,727) | $(8,377) | $(7,952) | $(4,356) |
| Net loss attributable to noncontrolling interests | (11,510) | (6,098) | (2,528) | (1,886) |
| Amortization expense | 30,394 | 26,899 | 82,286 | 76,334 |
| Share-based compensation | 22,017 | 17,949 | 51,772 | 46,764 |
| Change in fair value of contingent consideration | 1,980 | (952) | 8,084 | 17,276 |
| Transaction-related partnership and integration expenses | 2,376 | 2,047 | 7,894 | 9,042 |
| Loss on extinguishment and modification of debt | 3,290 | 389 | 5,684 | 15,068 |
| Depreciation | 1,649 | 1,557 | 4,874 | 4,619 |
| Severance | 1,620 | 678 | 4,445 | 3,554 |
| Other amortization/accretion, net | 486 | 1,422 | 3,329 | 4,419 |
| Transformation costs | 3,638 | — | 4,410 | — |
| Income tax expense(1) | — | — | 1,885 | 2,151 |
| Colleague earnout incentives | — | 4,327 | (1,779) | 10,706 |
| Impairment of right-of-use assets | 66 | — | 1,254 | — |
| Gain on divestitures | — | (1,809) | (290) | (38,953) |
| Loss on interest rate caps, net of cash settlements | — | 84 | 18 | 2,544 |
| Other(2) | 3,286 | 4,646 | 17,099 | 13,410 |
| Adjusted pre-tax income | 40,565 | 42,762 | 180,485 | 160,692 |
| Adjusted income taxes(3) | 4,016 | 4,234 | 17,868 | 15,909 |
| Adjusted net income | $36,549 | $38,528 | $162,617 | $144,783 |
| Weighted-average shares of Class A common stock outstanding - diluted | 68,605 | 64,012 | 67,572 | 63,001 |
| Dilutive weighted-average shares of Class A common stock | 3,265 | 4,014 | 3,320 | 3,570 |
| Exchange of Class B common stock(4) | 47,234 | 50,490 | 47,991 | 51,234 |
| Adjusted diluted weighted-average shares outstanding | 119,104 | 118,516 | 118,883 | 117,805 |
| Diluted loss per share | $(0.27) | $(0.13) | $(0.12) | $(0.07) |
| Effect of exchange of Class B common stock and net loss attributable to noncontrolling interests per share | 0.02 | 0.01 | 0.03 | 0.02 |
| Other adjustments to loss per share | 0.59 | 0.49 | 1.61 | 1.42 |
| Adjusted income taxes per share | (0.03) | (0.04) | (0.15) | (0.14) |
| Adjusted diluted EPS | $0.31 | $0.33 | $1.37 | $1.23 |
(1) Income tax expense includes the Tax Receivable Agreement expense.
(2) Other addbacks to adjusted net income include certain income and expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
(3) Represents corporate income taxes at an assumed effective tax rate of 9.9% applied to adjusted pre-tax income.
(4) Assumes the full exchange of Class B common stock for Class A common stock pursuant to the Amended LLC Agreement.
INSURANCE ADVISORY SOLUTIONS OPERATING GROUP RESULTS
IAS provides expertly-designed commercial risk management, employee benefits and private risk management solutions for businesses and high-net-worth individuals, as well as their families, through our national footprint, which has assimilated some of the highest quality independent insurance brokers in the country with vast and varied strategic capabilities and expertise.
(in thousands, except percentages)
| Revenues: | For the Three Months Ended September 30, 2025 | 2024 | Variance Amount% | For the Nine Months Ended September 30, 2025 | 2024 | Variance Amount% | ||
|---|---|---|---|---|---|---|---|---|
| Core commissions and fees | $142,222 | $141,169 | $1,053 | 1% | $516,810 | $495,561 | $21,249 | 4% |
| Profit-sharing and other income | 14,918 | 16,366 | (1,448) | (9)% | 49,332 | 49,823 | (491) | (1)% |
| Commissions and fees | 157,140 | 157,535 | (395) | —% | 566,142 | 545,384 | 20,758 | 4% |
| Investment income | 1,380 | 1,803 | (423) | (23)% | 3,316 | 4,426 | (1,110) | (25)% |
| Total revenues | 158,520 | 159,338 | (818) | (1)% | 569,458 | 549,810 | 19,648 | 4% |
| Operating expenses: | ||||||||
| Colleague compensation and benefits | 123,492 | 116,715 | 6,777 | 6% | 387,734 | 374,822 | 12,912 | 3% |
| Outside commissions | 2,151 | 2,551 | (400) | (16)% | 8,589 | 8,264 | 325 | 4% |
| Other operating expenses | 19,281 | 20,098 | (817) | (4)% | 61,336 | 59,328 | 2,008 | 3% |
| Amortization expense | 13,316 | 16,435 | (3,119) | (19)% | 40,075 | 46,087 | (6,012) | (13)% |
| Change in fair value of contingent consideration | 1,533 | (4,195) | 5,728 | (137)% | 8,203 | 9,709 | (1,506) | (16)% |
| Depreciation expense | 313 | 363 | (50) | (14)% | 939 | 1,094 | (155) | (14)% |
| Total operating expenses | 160,086 | 151,967 | 8,119 | 5% | 506,876 | 499,304 | 7,572 | 2% |
| Operating income (loss) | (1,566) | 7,371 | (8,937) | (121)% | 62,582 | 50,506 | 12,076 | 24% |
| Total other income, net | 1,121 | 1,828 | (707) | (39)% | 1,852 | 5,138 | (3,286) | (64)% |
| Income (loss) before income taxes and share of net earnings of equity method investment | $(445) | $9,199 | $(9,644) | (105)% | $64,434 | $55,644 | $8,790 | 16% |
Commissions and Fees
IAS generates (i) commissions for placing insurance policies on behalf of its insurance company partners; (ii) profit-sharing income based on either the underlying book of business or performance, such as loss ratios; and (iii) fees from consulting and service fee arrangements, which are in place with certain clients for a negotiated fee.
IAS commissions and fees decreased $0.4 million for the quarter ended September 30, 2025 compared to the same period of 2024, driven by a decrease in profit-sharing and other revenue, offset in part by an increase in core commissions and fees. Growth in our core commissions and fees was driven by 20% sales velocity (new business as a percentage of prior year commissions and fees) compared to 23% in the prior-year period. Organic growth was pressured by 570 bps of headwind in underlying rate and exposure during the quarter, attributable to softening insurance rates, as well as overall lower economic activity.
IAS commissions and fees increased $20.8 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to organic growth in core commissions and fees. Growth in our core commissions and fees was driven by 19% sales velocity compared to 21% in the prior-year period. Organic growth was pressured by 170 bps of headwind in underlying rate and exposure change year over year, attributable to softening insurance rates, particularly in the property line of business, as well as overall lower economic activity.
Colleague Compensation and Benefits
Colleague compensation and benefits expense for IAS increased $6.8 million for the quarter ended September 30, 2025 compared to the same period of 2024, primarily due to increases in inside advisor commissions of $6.4 million and colleague compensation of $5.0 million, offset in part by a decrease in colleague earnout incentives of $4.3 million.
Colleague compensation and benefits expense for IAS increased $12.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, primarily due to increases in colleague compensation of $12.0 million, inside advisor commissions of $8.8 million and benefits and other of $4.4 million, partially offset by a decrease in colleague earnout incentives of $12.4 million.
Other Operating Expenses
Other operating expenses for IAS increased $2.0 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to higher costs for professional fees of $3.0 million and advertising and marketing of $1.7 million, partially offset by lower legal settlement expense of $1.1 million.
Amortization Expense
Amortization expense for IAS decreased $3.1 million and $6.0 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, as a result of several trade names having reached the end of their useful lives over the past twelve months.
Change in Fair Value of Contingent Consideration
The change in fair value of contingent consideration for IAS was a $1.5 million loss for the quarter ended September 30, 2025 compared to a $4.2 million gain for the same period of 2024, and a $8.2 million loss for the year-to-date period ended September 30, 2025 compared to a $9.7 million loss for the same period of 2024. The fair value loss for the quarter ended September 30, 2025 was impacted by positive changes in revenue growth trends of certain partners. The fair value loss for the year-to-date period ended September 30, 2025 was impacted by positive changes in revenue growth trends of certain partners, in addition to a loss recognized in reclassifying $1.6 million of earnouts from colleague compensation and benefits.
UNDERWRITING, CAPACITY & TECHNOLOGY SOLUTIONS OPERATING GROUP RESULTS
UCTS consists of three distinct divisions—MSI, our Capacity Solutions group (which includes our reinsurance brokerage business, Juniper Re; our reinsurance MGA business, MultiStrat; and our captive management business), and the Captive business. Through MSI, we manufacture proprietary, technology-enabled insurance products with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, an example of which is our national embedded renters insurance product sold at point of lease via integrations with property management software providers. Our MGA product suite is now comprised of more than 20 products across personal, commercial and professional lines. UCTS’ Wholesale Business was sold in the first quarter of 2024, and its operations are included in our results through February 29, 2024.
(in thousands, except percentages)
| Revenues: | For the Three Months Ended September 30, 2025 | 2024 | Variance Amount% | For the Nine Months Ended September 30, 2025 | 2024 | Variance Amount% | ||
|---|---|---|---|---|---|---|---|---|
| Core commissions and fees | $140,297 | $124,079 | $16,218 | 13% | $402,726 | $343,552 | $59,174 | 17% |
| Profit-sharing and other income | 5,629 | 4,639 | 990 | 21% | 13,711 | 9,821 | 3,890 | 40% |
| Commissions and fees | 145,926 | 128,718 | 17,208 | 13% | 416,437 | 353,373 | 63,064 | 18% |
| Investment income | 1,341 | 1,076 | 265 | 25% | 3,514 | 2,803 | 711 | 25% |
| Total revenues | 147,267 | 129,794 | 17,473 | 13% | 419,951 | 356,176 | 63,775 | 18% |
| Operating expenses: | ||||||||
| Colleague compensation and benefits | 30,375 | 23,617 | 6,758 | 29% | 85,722 | 73,160 | 12,562 | 17% |
| Outside commissions | 75,492 | 74,420 | 1,072 | 1% | 207,371 | 195,658 | 11,713 | 6% |
| Other operating expenses | 18,499 | 11,086 | 7,413 | 67% | 50,347 | 32,473 | 17,874 | 55% |
| Amortization expense | 5,410 | 3,850 | 1,560 | 41% | 14,840 | 10,730 | 4,110 | 38% |
| Change in fair value of contingent consideration | 447 | 3,032 | (2,585) | (85)% | (398) | 7,355 | (7,753) | (105)% |
| Depreciation expense | 171 | 151 | 20 | 13% | 484 | 463 | 21 | 5% |
| Total operating expenses | 130,394 | 116,156 | 14,238 | 12% | 358,366 | 319,839 | 38,527 | 12% |
| Operating income | 16,873 | 13,638 | 3,235 | 24% | 61,585 | 36,337 | 25,248 | 69% |
| Total other income (expense), net | (119) | 57 | (176) | n/m | (352) | 34,133 | (34,485) | (101)% |
| Income before income taxes and share of net earnings of equity method investment | $16,754 | $13,695 | $3,059 | 22% | $61,233 | $70,470 | $(9,237) | (13)% |
n/m not meaningful
Commissions and Fees
UCTS generates (i) commissions for underwriting and placing insurance policies and/or treaties on behalf of its insurance company partners and reinsurance company partners; (ii) policy fee and installment fee revenue for acting in the capacity of an MGA and fulfilling certain administrative functions on behalf of insurance or reinsurance company partners, including delivery of policy documents, processing payments and other administrative functions; (iii) profit-sharing income, generally based on the profitability of the underlying book of business of the policies it generates on behalf of its insurance company partners and reinsurance company partners; (iv) fees from service fee arrangements, which are in place with certain clients for a negotiated fee; and (v) assumed premium earned in the Captive business.
UCTS commissions and fees increased $17.2 million for the quarter ended September 30, 2025 compared to the same period of 2024, due primarily to organic growth in core commissions and fees. Total growth in our core commissions and fees of $16.2 million for the quarter was driven by continued outperformance in MSI (accounting for $7.7 million of the increase in core commissions and fees), the introduction of the Captive (accounting for $5.9 million of the increase in core commissions and fees), and building momentum in our Capacity Solutions group (accounting for $3.2 million of the increase in core commissions and fees). Total growth in our core commissions and fees included the Partnership contribution of $4.5 million.
UCTS commissions and fees increased $63.1 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to organic growth in core commissions and fees. Total growth in our core commissions and fees of $59.2 million for the year-to-date period was driven by continued outperformance in MSI (accounting for $38.5 million of the increase in core commissions and fees), the introduction of the Captive (accounting for $15.7 million of the increase in core commissions and fees), and building momentum in our Capacity Solutions group (accounting for $11.1 million of the increase in core commissions and fees). Total growth in our core commissions and fees included the Partnership contribution of $6.2 million, as well as the impact of the divestiture of our Wholesale Business in the first quarter of 2024 of $(5.5) million. In addition, profit sharing and other increased $3.9 million for the year-to-date period. Core commissions and fees growth, excluding revenue related to the Wholesale Business during 2024, was 19%.
Colleague Compensation and Benefits
Colleague compensation and benefits expense for UCTS increased $6.8 million for the quarter ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $2.2 million to the increase in colleague compensation and benefits during the third quarter of 2025. After excluding colleague compensation and benefits expense related to Partnership activity, colleague compensation and benefits increased $4.5 million as a result of the growth in UCTS.
Colleague compensation and benefits expense for UCTS increased $12.6 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024. Partnership activity contributed $3.6 million to the increase in colleague compensation and benefits year-to-date in 2025, offset in part by a $1.4 million decrease related to divestiture activity during 2024. After excluding colleague compensation and benefits expense related to partnership and divestiture activity, colleague compensation and benefits increased $10.3 million as a result of the growth in UCTS.
Outside Commissions
Outside commissions for UCTS consist of outside commissions paid to partners that distribute our MGA products. Outside commissions for UCTS increased $1.1 million, or 1%, for the quarter ended September 30, 2025 compared to the same period of 2024. Outside commissions for the quarter increased at a lower rate than core commissions and fees due to continued scaling of the business, product mix shift and contributions from the Capacity Solutions group (which generally does not have significant outside commissions).
Outside commissions for UCTS increased $11.7 million, or 6%, for the year-to-date period ended September 30, 2025 compared to the same period of 2024. After excluding outside commissions of $3.0 million attributable to the Wholesale Business during 2024 for which there was no comparable expense in 2025, outside commissions for UCTS increased $14.7 million, or 8%. Outside commissions for the year-to-date period increased at a lower rate than core commissions and fees due to continued scaling of the business, product mix shift and increased contributions from the Capacity Solutions group (which generally does not have significant outside commissions).
Other Operating Expenses
Other operating expenses for UCTS increased $7.4 million for the quarter ended September 30, 2025 compared to the same period of 2024, driven by higher incurred losses and LAE of $5.1 million related to our newly-established Captive business and professional fees of $1.0 million due to increased legal spend.
Other operating expenses for UCTS increased $17.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by higher incurred losses and LAE of $14.0 million related to our newly-established Captive business, professional fees of $2.8 million due to increased legal spend, and licenses and taxes of $1.4 million.
Amortization Expense
Amortization expense for UCTS increased $1.6 million and $4.1 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, primarily due to an increase in capitalized software, as well as our partnership activity.
Change in Fair Value of Contingent Consideration
The change in fair value of contingent consideration for UCTS was a $0.4 million loss for the quarter ended September 30, 2025 compared to a $3.0 million loss for the same period of 2024, and a $0.4 million gain for the year-to-date period ended September 30, 2025 compared to a $7.4 million loss for the same period of 2024. The fair value gains and losses for the quarter and year-to-date periods ended September 30, 2025 were impacted by both positive and negative changes in revenue growth trends of its partners.
Total Other Income (Expense), Net
Total other income (expense), net for UCTS decreased $34.5 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by a $35.1 million gain recorded during 2024 in connection with the sale of our Wholesale Business.
MAINSTREET INSURANCE SOLUTIONS OPERATING GROUP RESULTS
MIS offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in their communities, with a focus on accessing clients via sheltered distribution channels, which include, but are not limited to, new home builders, realtors, mortgage originators/lenders, master planned communities, and various other community centers of influence. MIS also offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents.
(in thousands, except percentages)
| Revenues: | For the Three Months Ended September 30, 2025 | 2024 | Variance Amount% | For the Nine Months Ended September 30, 2025 | 2024 | Variance Amount% | ||
|---|---|---|---|---|---|---|---|---|
| Core commissions and fees | $65,403 | $61,983 | $3,420 | 6% | $198,362 | $192,971 | $5,391 | 3% |
| Profit-sharing and other income | 11,026 | 8,675 | 2,351 | 27% | 22,386 | 16,451 | 5,935 | 36% |
| Commissions and fees | 76,429 | 70,658 | 5,771 | 8% | 220,748 | 209,422 | 11,326 | 5% |
| Investment income | 47 | — | 47 | —% | 161 | — | 161 | —% |
| Total revenues | 76,476 | 70,658 | 5,818 | 8% | 220,909 | 209,422 | 11,487 | 5% |
| Operating expenses: | ||||||||
| Colleague compensation and benefits | 26,521 | 23,098 | 3,423 | 15% | 78,395 | 73,518 | 4,877 | 7% |
| Outside commissions | 18,646 | 19,274 | (628) | (3)% | 56,790 | 58,085 | (1,295) | (2)% |
| Other operating expenses | 9,498 | 9,123 | 375 | 4% | 28,841 | 25,765 | 3,076 | 12% |
| Amortization expense | 10,997 | 6,368 | 4,629 | 73% | 25,777 | 18,945 | 6,832 | 36% |
| Change in fair value of contingent consideration | — | 211 | (211) | (100)% | 279 | 212 | 67 | 32% |
| Depreciation expense | 180 | 190 | (10) | (5)% | 539 | 528 | 11 | 2% |
| Total operating expenses | 65,842 | 58,264 | 7,578 | 13% | 190,621 | 177,053 | 13,568 | 8% |
| Operating income | 10,634 | 12,394 | (1,760) | (14)% | 30,288 | 32,369 | (2,081) | (6)% |
| Total other income (expense), net | (172) | 4 | (176) | n/m | (668) | 2 | (670) | n/m |
| Income before income taxes and share of net earnings of equity method investment | $10,462 | $12,398 | $(1,936) | (16)% | $29,620 | $32,371 | $(2,751) | (8)% |
n/m not meaningful
Commissions and Fees
MIS generates (i) commissions for placing insurance policies on behalf of its insurance company partners; (ii) profit-sharing income based on either the underlying book of business or performance, such as loss ratios; and (iii) commissions and fees in the form of marketing income, which is earned through co-branded marketing campaigns with our insurance company partners.
MIS commissions and fees increased $5.8 million for the quarter ended September 30, 2025 compared to the same period of 2024. MIS core commissions and fees increased $3.4 million in total resulting from the recently acquired Hippo’s Homebuilder Distribution Network (accounting for $7.4 million of the increase in core commissions and fees), our national mortgage and real estate channel (accounting for $1.0 million of the increase in core commissions and fees) and our legacy Mainstreet business (accounting for $0.7 million of the increase in core commissions and fees). The overall growth was partially offset by lower core commissions and fees from our Medicare business of $2.8 million and our Westwood business of $2.7 million. In addition, MIS profit-sharing and other revenue increased $2.4 million resulting from improvements in loss ratios and the number of policies sold.
MIS commissions and fees increased $11.3 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024. MIS core commissions and fees increased $5.4 million in total resulting from the recently acquired Hippo’s Homebuilder Distribution Network (accounting for $7.4 million of the increase in core commissions and fees), our national mortgage and real estate channel (accounting for $1.3 million of the increase in core commissions and fees) and our legacy Mainstreet business (accounting for $1.0 million of the increase in core commissions and fees). The overall growth was partially offset by lower core commissions and fees from our Medicare business of $2.8 million. In addition, MIS profit-sharing and other revenue increased $5.9 million resulting from improvements in loss ratios and the number of policies sold.
Effective May 1, 2025, we are receiving reduced commissions from QBE Insurance Corporation and its affiliates on the portion of our builder-sourced homeowners book of business we are rolling into the Reciprocal; a temporary headwind that is expected to persist through the first half of 2026 before reversing into a tailwind.
Colleague Compensation and Benefits
Colleague compensation and benefits expense for MIS increased $3.4 million for the quarter ended September 30, 2025 compared to the same period of 2024. After excluding colleague compensation and benefits expense related to Partnership activity, colleague compensation and benefits increased $2.5 million, which is in line with the prior-year period as percentage of our core commissions and fees.
Colleague compensation and benefits expense for MIS increased $4.9 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024. After excluding colleague compensation and benefits expense related to Partnership activity, colleague compensation and benefits increased $4.0 million, which is in line with the prior-year period as percentage of our core commissions and fees.
Other Operating Expenses
Other operating expenses for MIS increased $3.1 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, driven by higher legal settlement expense of $0.7 million, rent expense of $0.5 million and technology and software-related costs of $0.4 million.
Amortization Expense
MIS amortization expense increased $4.6 million and $6.8 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, driven by our partnership activity and an increase in capitalized software.
CORPORATE AND OTHER RESULTS
(in thousands, except percentages)
| Revenues: | For the Three Months Ended September 30, 2025 | 2024 | Variance Amount% | For the Nine Months Ended September 30, 2025 | 2024 | Variance Amount% | ||
|---|---|---|---|---|---|---|---|---|
| Commissions and fees | $(17,178) | $(21,701) | $4,523 | (21)% | $(54,230) | $(57,770) | $3,540 | (6)% |
| Investment income | 304 | 849 | (545) | (64)% | 1,517 | 1,507 | 10 | 1% |
| Total revenues | (16,874) | (20,852) | 3,978 | (19)% | (52,713) | (56,263) | 3,550 | (6)% |
| Operating expenses: | ||||||||
| Colleague compensation and benefits | 12,643 | 9,215 | 3,428 | 37% | 34,671 | 27,859 | 6,812 | 24% |
| Outside commissions | (17,178) | (21,701) | 4,523 | (21)% | (54,230) | (57,770) | 3,540 | (6)% |
| Other operating expenses | 8,730 | 8,532 | 198 | 2% | 29,622 | 23,632 | 5,990 | 25% |
| Amortization expense | 671 | 246 | 425 | 173% | 1,594 | 572 | 1,022 | 179% |
| Depreciation expense | 985 | 853 | 132 | 15% | 2,912 | 2,534 | 378 | 15% |
| Total operating expenses | 5,851 | (2,855) | 8,706 | n/m | 14,569 | (3,173) | 17,742 | n/m |
| Operating loss | (22,725) | (17,997) | (4,728) | 26% | (67,282) | (53,090) | (14,192) | 27% |
| Other income (expense): | ||||||||
| Interest expense, net | (31,016) | (31,346) | 330 | (1)% | (92,060) | (94,230) | 2,170 | (2)% |
| Loss on divestitures | — | — | — | —% | (1,611) | — | (1,611) | —% |
| Loss on extinguishment and modification of debt | (3,290) | (389) | (2,901) | 746% | (5,684) | (15,068) | 9,384 | (62)% |
| Other income (expense), net | (86) | (35) | (51) | 146% | 1,446 | (188) | 1,634 | n/m |
| Total other expense, net | (34,392) | (31,770) | (2,622) | 8% | (97,909) | (109,486) | 11,577 | (11)% |
| Loss before income taxes and share of net earnings of equity method investment | $(57,117) | $(49,767) | $(7,350) | 15% | $(165,191) | $(162,576) | $(2,615) | 2% |
n/m not meaningful
Commissions and Fees
Corporate and Other records the elimination of intercompany commission revenue from the operating groups. During the quarter and year-to-date periods ended September 30, 2025, IAS recorded commission revenue shared with other operating groups of $0.1 million and $0.3 million, respectively, and UCTS recorded commission revenue shared with other operating groups of $17.1 million and $54.0 million, respectively.
Colleague Compensation and Benefits
Colleague compensation and benefits expense in Corporate and Other increased $3.4 million and $6.8 million for the quarter and year-to-date periods ended September 30, 2025 compared to the same periods of 2024, respectively, driven by increases in colleague compensation resulting from our continued growth.
Outside Commissions
Outside commissions for Corporate and Other results from the elimination of intercompany commission expense from the operating groups.
Other Operating Expenses
Other operating expenses in Corporate and Other increased $6.0 million for the year-to-date period ended September 30, 2025 compared to the same period of 2024, due primarily to higher technology and software-related costs of $2.7 million, professional fees of $1.0 million due to increased legal spend, and travel and entertainment of $0.8 million.
Interest Expense, Net
Interest expense, net, in Corporate and Other was relatively flat for the quarter ended September 30, 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset by higher average borrowings.
Interest expense, net, in Corporate and Other decreased $2.2 million year-to-date period ended September 30, 2025 compared to the same period of 2024 resulting from a lower average interest rate due to the 2025 Refinancings, offset in part by higher average borrowings. We expect interest expense to remain relatively flat in the near term on a year-over-year basis due to higher borrowings under our Revolving Facility to fund the settlement of deferred payment obligations and certain partnership opportunities, offset by lower expected average interest rates.
Loss on Extinguishment and Modification of Debt
Loss on extinguishment and modification of debt in Corporate and Other of $3.3 million for the quarter ended September 30, 2025 relates to the September 2025 Refinancing.
Loss on extinguishment and modification of debt in Corporate and Other of $5.7 million for the year-to-date period ended September 30, 2025 relates to the 2025 Refinancings. Loss on extinguishment and modification of debt of $15.1 million for the year-to-date period ended September 30, 2024 relates to a debt refinancing completed in May 2024.
LIQUIDITY AND CAPITAL RESOURCES
Our primary liquidity needs for the foreseeable future will include cash to (i) provide capital to facilitate the organic growth of our business and to fund future partnerships, (ii) pay operating expenses, including cash compensation to our colleagues and expenses related to being a public company, (iii) make payments under the Tax Receivable Agreement, (iv) pay interest and principal due on borrowings under the 2024 Credit Facility and the Senior Secured Notes, (v) pay contingent earnout liabilities, (vi) pay income taxes, and (vii) fund potential investments in third party businesses that support the growth of our business, which may include sponsorship of, and a minority, non-controlling interest in, other investment funds, the purpose of which may include facilitating the establishment of additional and alternative capacity that supports the growth of our MSI business.
We have historically financed our operations and funded our debt service through the sale of our insurance products and services, and we have financed significant cash needs to fund growth through the acquisition of partners through debt and equity financing.
As of September 30, 2025, the 2024 Credit Facility provides for senior secured credit facilities in an aggregate principal amount of $1.61 billion, which consists of (i) a term loan facility in the principal amount of $1.006 billion, bearing interest at a rate of term SOFR, plus an applicable margin of 250 bps, maturing May 24, 2031 (the “2025 Term Loan Facility”) and (ii) a revolving credit facility with commitments in an aggregate principal amount of $600 million, bearing interest at SOFR plus 185 bps to SOFR plus 260 bps based on total net leverage ratio, maturing May 24, 2029 (the “Revolving Facility”). As of September 30, 2025, we had $66.0 million outstanding under our Revolving Facility and $10.0 million of undrawn letters of credit issued thereunder.
As of September 30, 2025, Baldwin Holdings also had outstanding $600 million aggregate principal amount of 7.125% senior secured notes due May 15, 2031 (the “Senior Secured Notes”). Refer to Note 10 to our consolidated financial statements included in Part I, Item 1. Financial Statements of this report for more information relating to the terms of the Senior Secured Notes and 2024 Credit Facility.
During September 2025, we entered into a floating-to-fixed interest rate swap agreement with a notional amount of $500.0 million, which exchanges the variable rate of the Term Loans, which are indexed to 1-month term SOFR, for a fixed rate of 3.244%. Interest payments will be made on a monthly basis commencing on October 14, 2025 through the termination date of September 14, 2028. The objective of the swap, for which we elected hedge accounting, is to manage our exposure to interest rate risk by converting a portion of the floating rate cash flows of the Term Loans into fixed rate payments.
In the near term, we intend to fund our earnout obligations with cash and cash equivalents, including unused proceeds from the issuance of the Senior Secured Notes and the 2025 Term Loans, cash flow from operations and available borrowings under the Revolving Facility. From time to time, we will consider raising additional debt or equity financing if and as necessary to support our growth, including in connection with the exploration of partnership opportunities or to refinance existing obligations on an opportunistic basis.
In addition, we continue to evaluate our capital structure and current market conditions related to our capital structure. In addition to exploring partnership or refinancing opportunities, we may consider, if authorized by our Board of Directors, the repurchase of our common stock in open market or privately negotiated transactions. We have broad discretion over the deployment of our capital and these initiatives may not be successful or could limit our liquidity otherwise available.
As of September 30, 2025, our cash and cash equivalents were $89.7 million and we had $524 million of available borrowing capacity on the Revolving Facility. We believe that our cash and cash equivalents, cash flow from operations and available borrowings will be sufficient to fund our working capital and meet our commitments for the next twelve months and beyond.
Contractual Obligations and Commitments
The following table represents our contractual obligations and commitments, aggregated by type, at September 30, 2025:
(in thousands)
| Total | Payments Due by Period Less than 1 year | 1-3 years | 3-5 years | More than 5 years | |
|---|---|---|---|---|---|
| Operating leases(1) | $89,534 | $21,404 | $37,813 | $24,645 | $5,672 |
| Debt obligations payable(2) | 2,309,210 | 124,217 | 245,321 | 302,596 | 1,637,076 |
| Undiscounted estimated contingent earnout obligation(3) | 33,592 | 17,722 | 11,802 | 1,987 | 2,081 |
| USF Grant | 3,352 | 856 | 1,696 | 800 | — |
| Total | $2,435,688 | $164,199 | $296,632 | $330,028 | $1,644,829 |
(1) Represents noncancelable operating leases for our facilities. Operating lease expense was $15.8 million and $16.2 million for the nine months ended September 30, 2025 and 2024, respectively.
(2) Represents scheduled debt obligations and estimated interest payments for our Senior Secured Notes, 2025 Term Loans and the Revolving Facility.
(3) Represents the total expected future payments to be made to partners and colleagues for earnout-related obligations at September 30, 2025.
Our contractual obligations and commitments are comprised of operating lease obligations, principal and interest payments on our borrowings under the Senior Secured Notes, the 2025 Term Loans and the Revolving Facility, estimated payments of contingent earnout liabilities, and our commitment to the University of South Florida (“USF”).
Our operating lease obligations represent noncancelable agreements for our corporate headquarters and office space for our insurance brokerage business. Our operating lease agreements expire through August 2035. These obligations do not include leases with an initial term of twelve months or less, which are expensed as incurred. We may extend, terminate or otherwise modify or sub-lease facilities as needed to best suit the needs of our business. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised.
Our debt obligations at September 30, 2025 include borrowings outstanding under the Senior Secured Notes of $600 million, the 2025 Term Loans of $1.004 billion, and the Revolving Facility of $66.0 million. Estimated interest payments for outstanding borrowings under the Senior Secured Notes, 2025 Term Loans, and Revolving Facility in the table above were calculated based on the applicable interest rates at September 30, 2025 of 7.125%, 6.64% and 6.82%, respectively, through their respective due dates of May 15, 2031, May 24, 2031 and May 24, 2029.
Substantially all of our partnerships and certain acquisitions of select books of business that do not constitute a complete business enterprise include contractual earnout provisions. We record an estimation of the fair value of the contingent earnout obligations at the partnership date as a component of the consideration paid. Our contingent earnout obligations are measured at fair value each reporting period based on the present value of the expected future payments to be made to partners in accordance with the provisions outlined in the respective purchase agreements. The recorded obligations are based on estimates of the partners’ future performance using financial projections for the earnout period. The aggregate estimated contingent earnout liabilities included on our condensed consolidated balance sheet of $28.4 million at September 30, 2025 includes $10.0 million that must be settled in cash and the remaining $18.4 million can be settled in cash or stock at our option. The undiscounted estimated contingent earnout obligation presented in the table above represents the total expected future payments to be made to the partners. The undiscounted estimated contingent earnout obligation of $33.6 million at September 30, 2025 includes $10.0 million that must be settled in cash and the remaining $23.6 million can be settled in cash or stock at our option can be settled in cash or stock at our option. The maximum estimated exposure to the contingent earnout liabilities was $65.5 million at September 30, 2025.
As of September 30, 2025, we have a remaining commitment to USF to donate $3.4 million through October 2028. The gift will provide support for the School of Risk Management and Insurance in the USF Muma College of Business. It is currently anticipated that Lowry Baldwin, our Chairman, will fund half of this commitment.
Tax Receivable Agreement
We expect to obtain an increase in our share of the tax basis in the assets of Baldwin Holdings when its LLC Units are redeemed or exchanged for shares of Baldwin’s Class A common stock. This increase in tax basis may have the effect of reducing the future amounts paid to various tax authorities. The increase in tax basis may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.
We have a Tax Receivable Agreement that provides for the payment by us to the parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that we actually realize as a result of (i) any increase in tax basis in Baldwin’s assets and (ii) tax benefits related to imputed interest deemed arising as a result of payments made under the Tax Receivable Agreement.
During the nine months ended September 30, 2025, we redeemed 2,383,868 LLC Units of Baldwin Holdings on a one-for-one basis for shares of Class A common stock and cancelled the corresponding shares of Class B common stock. We receive an increase in our share of the tax basis in the net assets of Baldwin Holdings due to the interests being redeemed. We have assessed the realizability of the net deferred tax assets and in that analysis have considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. We have recorded a full valuation allowance against the deferred tax assets at Baldwin as of September 30, 2025, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.
As of September 30, 2025 and December 31, 2024, we have recorded a Tax Receivable Agreement liability of $5.2 million and $4.8 million, respectively, associated with the payments to be made to current or former Baldwin Holdings’ LLC Members subject to the Tax Receivable Agreement.
Sources and Uses of Cash
The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:
(in thousands)
| For the Nine Months Ended September 30, 2025 | 2024 | Variance | |
|---|---|---|---|
| Net cash provided by (used in) operating activities | $(39,687) | $53,754 | $(93,441) |
| Net cash provided by (used in) investing activities | (129,577) | 25,609 | (155,186) |
| Net cash provided by financing activities | 182,439 | 38,390 | 144,049 |
| Net increase in cash and cash equivalents and fiduciary cash | 13,175 | 117,753 | (104,578) |
| Cash and cash equivalents and fiduciary cash at beginning of period | 312,769 | 226,963 | 85,806 |
| Cash and cash equivalents and fiduciary cash at end of period | $325,944 | $344,716 | $(18,772) |
53
Operating Activities
The primary sources and uses of cash for operating activities are net income (loss) adjusted for non-cash items and changes in assets and liabilities, or operating working capital, and payment of contingent earnout consideration. Net cash used in operating activities increased $93.4 million year over year, primarily as a result of a $63.9 million increase in payments of contingent earnout consideration in excess of purchase price accrual.
Investing Activities
The primary sources and uses of cash for investing activities relate to cash consideration paid to fund partnerships, proceeds from divested assets, and other investments to grow our business. Net cash used in investing activities increased $155.2 million year over year driven by a decrease in cash proceeds from divestitures, net of cash transferred of $55.1 million relating primarily to the sale of our Wholesale Business during 2024, an increase in investments in and loans for business ventures of $14.1 million related to our investment in the Reciprocal in 2025, and an increase in cash consideration paid for partnership activity of $85.7 million.
Financing Activities
The primary sources and uses of cash for financing activities relate to the issuance of our Class A common stock; debt servicing costs in connection with our long-term debt and revolving line of credit, as well as purchases, sales and settlements of interest rate caps to mitigate interest rate volatility on that debt; payment of contingent earnout consideration; and other equity transactions. Net cash provided by financing activities increased $144.0 million year over year driven by an increase in net proceeds from borrowings on our credit facilities of $153.5 million primarily resulting from the 2025 Refinancings and borrowings on the Revolving Facility to fund partnerships and the payment of our earnout obligations during 2025. This increase was partially offset by a decrease in cash of $18.5 million related to the change in fiduciary receivables and liabilities.
CRITICAL ACCOUNTING ESTIMATES
Our consolidated financial statements are prepared in accordance with GAAP, which requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Our estimates, judgments and assumptions are continually evaluated based on historical experience, known or expected trends, independent valuations and other factors we believe to be reasonable under the circumstances. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.
During the nine months ended September 30, 2025, we amended our critical accounting estimates to include the valuation of acquired relationships, the determination of which could have a significant impact on our results of operations.
Valuation of Acquired Relationships—We acquire significant intangible assets in connection with our strategic acquisitions of a business and, typically, acquired relationships are the most significant definite-lived intangible asset acquired. We engage a third-party valuation expert to determine the fair value of these assets, which generally involves the use of a discounted cash flow approach that is derived from historical information, future revenue and operating profit margins, contributory asset charges, and the selection of an appropriate discount rate, and requires management to make significant estimates and assumptions.
The Company’s critical accounting policies and estimates are described under Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2024. With the exception of the addition of the valuation of acquired relationships as discussed above, there have been no material changes to the critical accounting policies and estimates disclosed in out Annual Report on Form 10-K for the year ended December 31, 2024.
RECENT ACCOUNTING PRONOUNCEMENTS
Please refer to Note 1 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.
Market risk
As filed, 2,768 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Market risk is the potential loss arising from adverse changes in market rates and prices, such as premium amounts, interest rates and equity prices. We are exposed to market risk through our investments and borrowings under the 2024 Credit Facility. We use derivative instruments to mitigate our risk related to the effect of rising interest rates on our cash flows. However, we do not use derivative instruments for trading or speculative purposes.
Our invested assets are held primarily as cash and cash equivalents and restricted cash. To a lesser extent, we may also utilize certificates of deposit, U.S. treasury securities and professionally managed short duration fixed income funds. These investments are subject to market risk. The fair value of our invested assets at September 30, 2025 and December 31, 2024 approximated their respective carrying values due to their short-term duration and therefore, such market risk is not considered to be material.
During September 2025, the 2024 Credit Agreement was amended to, among other things, (i) reprice the Existing 2025 Term Loans with interest at term SOFR, plus an applicable margin of 250 bps; (ii) provide for $75.0 million of incremental term B loans; and (iii) reduce the applicable margin for the Revolving Facility to term SOFR, plus a credit spread adjustment of 10 bps, plus an applicable margin of 175 bps to 250 bps based on total net leverage ratio.
Also during September 2025, we entered into a floating-to-fixed interest rate swap agreement with a notional amount of $500.0 million, which exchanges the variable rate of the Term Loans, which are indexed to 1-month term SOFR, for a fixed rate of 3.244%. The objective of the swap, for which we elected hedge accounting, is to manage our exposure to interest rate risk by converting a portion of the floating rate cash flows of the Term Loans into fixed rate payments. This strategy provides predictability in interest expense and aligns with our risk management policy.
At September 30, 2025, we had outstanding borrowings of $1.004 billion under the Term Loans and $66.0 million under our Revolving Facility. Taking the interest rate swap into consideration, an increase of 100 basis points on the SOFR rate at September 30, 2025 would have increased our annual interest expense under the 2024 Credit Facility by $5.7 million.
Other than the amendments to the 2024 Credit Agreement to increase the aggregate principal amount of the 2025 Term Loans to $1.006 billion and the interest rate swap agreement, there have been no material changes in market risk from the information presented in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2024.
Controls and procedures
As filed, 1,530 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2025 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our senior management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosures.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2025, which were identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 189 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Please refer to the risk factors outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 25, 2025.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $362.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $1.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months2025-07-01 to 2025-09-30 | $3.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-01-01 to 2025-09-30 | $87.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $685.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | −$18.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | −$8.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | −$0.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | −$0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 68,604,951 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 67,571,899 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | −$39.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-01-01 to 2025-09-30 | $29.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2025-09-30 | $89.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-09-30 | $1.11bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-09-30 | $3.79bn | us-gaap:Assets |
| Current liabilities | At period end2025-09-30 | $959.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-09-30 | $2.67bn | us-gaap:Liabilities |
| Current portion of debt | At period end2025-09-30 | $10.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-09-30 | $619.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001781755-25-000109. Last ingested by Listed: Nov 10, 2026, 03:23 ET. Listed shows no prices and gives no investment advice.